ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.

Ana Oaknin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.